InsidersTradesSigma
Follow the ST万邦 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST万邦 has published 2 insider filings. Market capitalisation: €5.5bn. The latest transaction was disclosed on 13 October 2025 (Sale). Among the most active insiders: 庄惠. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
ST万邦 is a company in the healthcare and pharmaceutical sector, listed on the XSHE market. It specializes in the development and marketing of pharmaceutical products.